New Ultrasound Technique Provides Clear Look at Hard- to-Diagnose Breast Cysts

Publication
Article
OncologyONCOLOGY Vol 15 No 9
Volume 15
Issue 9

A new ultrasound technique called breast harmonic imaging can be successfully used to diagnose hard-to-see breast cysts,

A new ultrasound technique called breast harmonic imaging can be successfully used to diagnose hard-to-see breast cysts, thus eliminating the need for some biopsies,according to a study presented at a recent American Roentgen Ray Society meetingheld in Seattle, Washington.

The study—which involved 30 patients with 117 breast cysts—found thatharmonic imaging provides higher resolution and better detail of small cysts orcysts that are deeper in the breast than can be detected by conventionalultrasound, said Derek Muradali, MD, of the University Health Network and MountSinai Hospital in Toronto, Canada.

Patients in the study underwent a conventional ultrasound examination and aharmonic imaging examination. Two radiologists reviewed the conventionalultrasound images and the harmonic images and found that the harmonic imageswere "superior to conventional ultrasound" in 80% of cases. Theradiologists did not know which images were conventional or harmonic when theymade their assessment.

Future Standard of Care?

"Harmonic imaging is now available on some ultrasound machines, and wesimply flip a switch on the machine to change to the harmonic image," saidDr. Muradali. Harmonic imaging has been used in the past, but it is onlyrecently that the linear transducers used in breast ultrasound have becomeavailable for use in harmonic imaging.

Harmonic imaging will likely become the standard of care for patients withcysts that are difficult to diagnose with conventional ultrasound, said Dr.Muradali. "In the past, we’ve been obliged to biopsy small cysts or thosedeep in the breast, because conventional ultrasound hasn’t provided the detailneeded to accurately diagnose them. Harmonic imaging provides us with the meansto avoid doing those biopsies." This saves the patient and the physiciantime, effort, and money, said Dr. Muradali.

Newsletter

Stay up to date on recent advances in the multidisciplinary approach to cancer.

Recent Videos
The use of chemotherapy trended towards improved recurrence-free intervals in older patients with high-risk tumors as determined via the MammaPrint assay.
Use of a pharmacist-directed resource appears to improve provider confidence and adverse effect monitoring for patients undergoing infusion therapy.
Reshma L. Mahtani, DO, describes how updates from the DESTINY-Breast09, ASCENT-04, and VERITAC-2 trials may shift practices in the breast cancer field.
Multidisciplinary care can help ensure that treatment planning does not deviate from established guidelines for inflammatory breast cancer management.
Photographic and written documentation can help providers recognize inflammatory breast cancer symptoms across diverse populations.
The use of guideline-concordant care in breast cancer appears to be more common in White populations than Black populations.
Strict inclusion criteria may disproportionately exclude racial minority populations from participating in breast cancer trials.
Related Content